News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,293 Results
Type
Article (40000)
Company Profile (286)
Press Release (649007)
Section
Business (204594)
Career Advice (2041)
Deals (35515)
Drug Delivery (85)
Drug Development (81102)
Employer Resources (168)
FDA (16182)
Job Trends (14909)
News (345866)
Policy (32598)
Tag
Academia (2552)
Alliances (49318)
Alzheimer's disease (1231)
Approvals (16111)
Artificial intelligence (131)
Bankruptcy (354)
Best Places to Work (11592)
Biotechnology (206)
Breast cancer (122)
Cancer (1096)
Cardiovascular disease (98)
Career advice (1702)
Cell therapy (236)
Clinical research (64460)
Collaboration (391)
Compensation (201)
COVID-19 (2539)
C-suite (97)
Data (1130)
Diabetes (154)
Diagnostics (6199)
Earnings (84968)
Employer resources (146)
Events (110139)
Executive appointments (313)
FDA (16724)
Funding (357)
Gene therapy (178)
GLP-1 (578)
Government (4352)
Healthcare (18763)
Infectious disease (2624)
Inflammatory bowel disease (106)
Interviews (321)
IPO (16349)
Job creations (3682)
Job search strategy (1453)
Layoffs (421)
Legal (7891)
Lung cancer (171)
Manufacturing (176)
Medical device (13257)
Medtech (13262)
Mergers & acquisitions (19245)
Metabolic disorders (404)
Neuroscience (1510)
NextGen Class of 2024 (6563)
Non-profit (4483)
Northern California (1484)
Obesity (232)
Opinion (181)
Patents (103)
People (56502)
Phase I (20056)
Phase II (28408)
Phase III (21168)
Pipeline (459)
Postmarket research (2560)
Preclinical (8531)
Radiopharmaceuticals (238)
Rare diseases (222)
Real estate (5931)
Regulatory (21628)
Research institute (2323)
Resumes & cover letters (354)
Southern California (1315)
Startups (3597)
United States (13629)
Vaccines (550)
Weight loss (168)
Date
Today (93)
Last 7 days (687)
Last 30 days (3779)
Last 365 days (36005)
2024 (33047)
2023 (40269)
2022 (51357)
2021 (55887)
2020 (54267)
2019 (46801)
2018 (35192)
2017 (32505)
2016 (31787)
2015 (37747)
2014 (31468)
2013 (26509)
2012 (28716)
2011 (29408)
2010 (27464)
Location
Africa (726)
Arizona (193)
Asia (37427)
Australia (6102)
California (3351)
Canada (1298)
China (252)
Colorado (150)
Connecticut (161)
Europe (80401)
Florida (462)
Georgia (116)
Illinois (345)
Indiana (196)
Kansas (96)
Maryland (582)
Massachusetts (2649)
Michigan (158)
Minnesota (276)
New Jersey (970)
New York (967)
North Carolina (723)
Northern California (1484)
Ohio (139)
Pennsylvania (849)
South America (1114)
Southern California (1315)
Texas (468)
Utah (90)
Washington State (365)
689,293 Results for "x therma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
X-Therma Achieves GMP Commercial Readiness with XT-Thrive®
X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has achieved GMP commercial readiness with its flagship product, XT-Thrive®.
May 29, 2024
·
3 min read
Biotech Bay
X-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)
X-Therma Inc , announces that the Food and Drug Administration (FDA) accepted a Drug Master File (DMF) covering its product, XT-Thrive ® .
April 17, 2024
·
2 min read
Therma Bright Completes Debt Settlements
Toronto, Ontario--(Newsfile Corp. - June 19, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies, announces...
June 19, 2024
·
3 min read
Biotech Bay
X-Therma’s $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation
X-Therma Inc., a biotechnology company developing a breakthrough platform for regenerative medicine and organ preservation, has completed an oversubscribed $22.4 million Series B funding round.
March 13, 2024
·
5 min read
Therma Bright Closes Second & Final Tranche of Fully Subscribed Non-Brokered Private Placement
Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies
June 21, 2024
·
4 min read
Therma Bright Closes $854,500 First Tranche of Non-Brokered Private Placement
Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), a developer and investment partner in a wide range of leading-edge, proprietary diagnostic and medical device technologies
June 10, 2024
·
5 min read
Therma Bright Announces up to $1,000,000 Unit Offering
Toronto, Ontario--(Newsfile Corp. - May 22, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), developer and partner in a wide-range of leading-edge, proprietary diagnostic and medical device technologies, announces that...
May 22, 2024
·
6 min read
Press Releases
Therma Bright Announces Shares for Debt Issuance
October 18, 2024
·
3 min read
Therma Bright Announces Strategic Review & Update on Investment in Inretio
Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (“Therma” or the “Company”), developer and partner in a wide-range of leading-edge, proprietary diagnostic and medical device technologies
March 21, 2024
·
3 min read
Press Releases
Therma Bright to Spin Off Consumer Product Portfolio to Create Two Publicly Traded Companies
November 18, 2024
·
5 min read
1 of 68,930
Next
